Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Automated Drawing Process Metrics for Evaluating Cognitive Impairment from Human Drawing Behavior
S15 - Innovative Diagnostics in Dementia

The digital Clock Drawing Task extracts cognitive- and motor-related features, enabling automatic CI detection in 3 minutes. Here, we applied the BPA to 4 other assessments to expand upon that capability.

To evaluate four novel tablet-based drawing assessments for detecting cognitive impairment (CI) using automated analysis of traditional and Boston Process Approach (BPA) features.

Novel process-based metrics captured during drawing/writing of Trails A/B, Symbol Digit Modalities Test (SDMT), Spiral Tracing, and Pathfinding were analyzed in two independent datasets: (1) 170 cognitively normal (CN) subjects to calculate test-retest reliability of features, and (2) 1000 CN and cognitively impaired (CI) subjects to quantify their group differences.

Average reliability was good across features; SDMT: r=0.54 (s.d.=0.2, range=-0.02–0.92), Trails B: r=0.42 (s.d.=0.25, range=-0.19–0.87), Spiral Tracing: r=0.5 (s.d.=0.19, range=-0.07–0.78), Pathfinding: r=0.47 (s.d.=0.2, range=0.07–0.78). Trails: CN drew faster and spent less time in each circle (|T|’s>2.8, p’s<0.001); SDMT: CI spent less time thinking/pausing (T=-4.01, p<0.0001) and more time writing (T=9.73, p<0.001); Pathfinding: CI drew faster with higher acceleration  (T=3.51, p<0.0001) and drew less (T=-6.48, p<0.0001); Spiral Tracing: CN deviated less (T=-2.88, p<0.0001), had lower velocity (T=-5.22, p<0.0001), and spent a larger portion of time drawing (T=11.57, p<0.0001) with less variability (T=-3.83, p<0.0001).

Our results demonstrate the value of process-based metrics during neuropsychological tasks in distinguishing between CN and CI individuals with fair-to-good test-retest reliability, thereby identifying specific processes that can lead to actionable recommendations.

Authors/Disclosures
Claudio Toro-Serey, PhD (Linus Health)
PRESENTER
Dr. Toro-Serey has received personal compensation for serving as an employee of Linus Health.
Alvaro Pascual-Leone, MD, PhD, FAAN (Marcus Institute for Aging Research & Wolk Center for Memory Health) Dr. Pascual-Leone has received personal compensation for serving as an employee of Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magstim. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroelectrics. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TetraNeuron. Dr. Pascual-Leone has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Pascual-Leone has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Linus Health. Dr. Pascual-Leone has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Pascual-Leone has stock in TI Solutions. The institution of Dr. Pascual-Leone has received research support from NIH. The institution of Dr. Pascual-Leone has received research support from NSF. The institution of Dr. Pascual-Leone has received research support from Brightfocus Foundation . Dr. Pascual-Leone has received intellectual property interests from a discovery or technology relating to health care. Dr. Pascual-Leone has received publishing royalties from a publication relating to health care.
Ali Jannati, MD, PhD (BIDMC, Harvard Medical School) Dr. Jannati has received personal compensation for serving as an employee of Linus Health. Dr. Jannati has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Children's Hospital, Harvard Medical School.
Sean Tobyne, PhD (Linus Health) Dr. Tobyne has received personal compensation for serving as an employee of Linus Health. Dr. Tobyne has received personal compensation for serving as an employee of Charles River Analytics. Dr. Tobyne has received stock or an ownership interest from Charles River Analytics. The institution of Dr. Tobyne has received research support from National Institutes of Health. The institution of Dr. Tobyne has received research support from Department of Defense.
Connor Patrick Higgins, Other (Linus Health) Mr. Higgins has received personal compensation for serving as an employee of Infosys Ltd.
David James Bates, PhD (Linus Health) Dr. Bates has received personal compensation for serving as an employee of Linus Health. Dr. Bates has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for TMCity Foundation. Dr. Bates has received stock or an ownership interest from Linus Health, Inc.. Dr. Bates has received intellectual property interests from a discovery or technology relating to health care. Dr. Bates has received intellectual property interests from a discovery or technology relating to health care.
Joyce Rios Gomes-Osman, PhD (Linus Health) Dr. Gomes-Osman has received personal compensation for serving as an employee of Linus Health. Dr. Gomes-Osman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Neurologic Physical Therapy.
Russell E. Banks, PhD (Linus Health Inc) Mr. Banks has received personal compensation for serving as an employee of Linus Health Inc.
John W. Showalter, MD (Linus Health) Dr. Showalter has received personal compensation for serving as an employee of Linus Health. Dr. Showalter has stock in Linus Health.